Cargando…

CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer

BACKGROUND: Cisplatin (CDDP) has become a standard-of-care treatment for muscle-invasive bladder cancer (MIBC), while chemoresistance remains a major challenge. Accumulating evidence indicates that circular RNAs (circRNAs) are discrete functional entities. However, the regulatory functions as well a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hui, Xiao, Xingyuan, Wei, Wenjie, Huang, Chao, Wang, Miao, Wang, Liang, He, Yuanqiao, Sun, Jiayin, Jiang, Yangkai, Jiang, Guosong, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054397/ https://www.ncbi.nlm.nih.gov/pubmed/33874956 http://dx.doi.org/10.1186/s12943-021-01360-4

Ejemplares similares

Downregulation of circLIFR exerts cancer-promoting effects on hepatocellular carcinoma in vitro
por: Ji, Jingzhang, et al.
Publicado: (2022)

CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway
por: Yang, Lei, et al.
Publicado: (2022)

Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern
por: Wiesendanger, Margrit, et al.
Publicado: (2000)

MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
por: Clark, Nicole, et al.
Publicado: (2013)

DNA Damage Induced MutS Homologue hMSH4 Acetylation
por: Chu, Yen-Lin, et al.
Publicado: (2013)

Multiple Losses of MSH1, Gain of mtMutS, and Other Changes in the MutS Family of DNA Repair Proteins in Animals
por: Muthye, Viraj, et al.
Publicado: (2021)

Schizosaccharomyces pombe MutSα and MutLα Maintain Stability of Tetra-Nucleotide Repeats and Msh3 of Hepta-Nucleotide Repeats
por: Villahermosa, Desirée, et al.
Publicado: (2017)

MutS homologue hMSH5: role in cisplatin-induced DNA damage response
por: Tompkins, Joshua D, et al.
Publicado: (2012)

Long-Range Signaling in MutS and MSH Homologs via Switching of Dynamic Communication Pathways
por: Wang, Beibei, et al.
Publicado: (2016)

Examination of Msh6- and Msh3-deficient Mice in Class Switching Reveals Overlapping and Distinct Roles of MutS Homologues in Antibody Diversification
por: Li, Ziqiang, et al.
Publicado: (2004)

Circular RNA circARPP21 Acts as a Sponge of miR-543 to Suppress Hepatocellular Carcinoma by Regulating LIFR
por: Gu, Yichao, et al.
Publicado: (2021)

MutS Homologue hMSH5: Recombinational DSB Repair and Non-Synonymous Polymorphic Variants
por: Wu, Xiling, et al.
Publicado: (2013)

Targeting LIF/LIFR signaling in cancer
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2021)

CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
por: Xie, Fei, et al.
Publicado: (2021)

Correction: CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
por: Xie, Fei, et al.
Publicado: (2022)

Mutation of the ATPase Domain of MutS Homolog-5 (MSH5) Reveals a Requirement for a Functional MutSγ Complex for All Crossovers in Mammalian Meiosis
por: Milano, Carolyn R., et al.
Publicado: (2019)

MutSβ abundance and Msh3 ATP hydrolysis activity are important drivers of CTG•CAG repeat expansions
por: Keogh, Norma, et al.
Publicado: (2017)

An integrative pan-cancer analysis reveals the oncogenic role of mutS homolog 6 (MSH6) in human tumors
por: Zhan, Haibo, et al.
Publicado: (2021)

A Pan-Cancer Analysis on the Systematic Correlation of MutS Homolog 2 (MSH2) to a Malignant Tumor
por: Yao, Hai, et al.
Publicado: (2022)

MutS homologue hMSH4: interaction with eIF3f and a role in NHEJ-mediated DSB repair
por: Chu, Yen-Lin, et al.
Publicado: (2013)

The ILEI/LIFR complex induces EMT via the Akt and ERK pathways in renal interstitial fibrosis
por: Zhou, Jieqing, et al.
Publicado: (2022)

Molecular Iodine/Cyclophosphamide Synergism on Chemoresistant Neuroblastoma Models
por: Álvarez-León, Winniberg, et al.
Publicado: (2021)

MutS/MutL crystal structure reveals that the MutS sliding clamp loads MutL onto DNA
por: Groothuizen, Flora S, et al.
Publicado: (2015)

Potential Influence of Age and Diabetes Mellitus Type 1 on MSH2 (MutS homolog 2) Expression in a Rat Kidney Tissue
por: Babić, Paško, et al.
Publicado: (2022)

Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology
por: Mikelonis, Dawn, et al.
Publicado: (2014)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
por: Blankenship, Logan, et al.
Publicado: (2022)

The Presence of the DNA Repair Genes mutM, mutY, mutL, and mutS is Related to Proteome Size in Bacterial Genomes
por: Garcia-Gonzalez, Aurian, et al.
Publicado: (2012)

ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells
por: Chen, Chi-Wei, et al.
Publicado: (2020)

A Homozygous Loss-of-Function Mutation in MSH5 Abolishes MutSγ Axial Loading and Causes Meiotic Arrest in NOA-Affected Individuals
por: Gong, Chenjia, et al.
Publicado: (2022)

Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73
por: Thangasamy, Thilakavathy, et al.
Publicado: (2010)

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
por: Tang, Weiwei, et al.
Publicado: (2021)

Long Noncoding RNA LIFR-AS1: A New Player in Human Cancers
por: Bai, Zhiqun, et al.
Publicado: (2022)

LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
por: Liu, Fang, et al.
Publicado: (2022)

Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity
por: Zheng, Shuang, et al.
Publicado: (2023)

MutSβ exceeds MutSα in dinucleotide loop repair
por: Kantelinen, J, et al.
Publicado: (2010)

circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex
por: Xie, Fei, et al.
Publicado: (2020)

High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma
por: Guo, Hongwei, et al.
Publicado: (2015)

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
por: Li, Mengxing, et al.
Publicado: (2021)

HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer
por: Clements, Miranda E., et al.
Publicado: (2021)

The LIFR-targeting small molecules EC330/EC359 are potent ferroptosis inducers
por: Feng, Chang-Zhou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hd9ph46gfoj91f7jta2uiekutn